Hawk70 say we remove the drug completely from the portfolio of NYR because the drug magically disappeared and NYR had nothing but their funding position, the market cap is their funding position right now lol that’s how dumb this share price is that’s it’s not only pricing in no potential but also below CEO and director shares coming in this week on Thursday.
If they want they can announce they have acquired a REE tenement in WA and the share price will be 300-400 percent up in a day with that funding position lol. Any biotech with this cash position and the potential from a drug like this on multiple preclinical study successes should be well above a 50 million market cap and on phase 1 a 70-100 million market cap. This is not a 10 million dollar valuation
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-63
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $9.839M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.2¢ | $6.978K | 131.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2029207 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 49999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| NYR (ASX) Chart |